Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Reference Cetrorelix Acetate in IVF
NCT06023602Recruiting
- Sponsor
- Northwest Women's and Children's Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cetrorelix in infertility (2 arms), sponsored by Northwest Women's and Children's Hospital. Primary endpoint: Cumulative live birth rate at 18 months. Started Feb 2024; status: recruiting.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06023602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06023602.